Literature DB >> 11084122

Video-assisted thoracoscopic treatment for spontaneous pneumothorax as two-day surgery.

R Maruyama1, T Oka, H Anai.   

Abstract

BACKGROUND: To see whether video-assisted thoracoscopic surgery (VATS) for spontaneous pneumothorax (SP) as 2-day surgery is a safe and cost-effective procedure, we retrospectively compared VATS as 2-day surgery with standard VATS.
METHODS: From April 1994 to March 2000, 139 SP patients were operated on: 115 patients were operated on by means of standard VATS and 24 were treated by 2-day surgery. The parameters we compared were the postoperative complications, hospitalization cost, and relapses.
RESULTS: Excepting that 2 of those selected for 2-day surgery required another hospitalization, short-term complications were considered to be similar for the two groups. The median economic cost of 2-day surgery was about $5,822 US dollars and was lower than that of standard VATS. The difference in the recurrence rate between the two groups was not significant.
CONCLUSIONS: We conclude that VATS as 2-day surgery is a safe and cost-effective procedure.

Entities:  

Mesh:

Year:  2000        PMID: 11084122     DOI: 10.1016/s0002-9610(00)00448-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

Review 1.  Optimal strategy for the first episode of primary spontaneous pneumothorax in young men. A decision analysis.

Authors:  Takeshi Morimoto; Tsuguya Fukui; Hiroshi Koyama; Yoshinori Noguchi; Takuro Shimbo
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

2.  Video-assisted thoracoscopic treatment as two-day surgery for lung neoplasms: a propensity-matched analysis.

Authors:  Guofei Zhang; Junqiang Fan; Zipu Yu; Ying Chai; Sai Zhang; Ming Wu; Gang Shen
Journal:  BMC Cancer       Date:  2022-07-30       Impact factor: 4.638

3.  Four years' experience in uniportal video-assisted thoracoscopic surgery for major lung resections: influence of silicosis in clinical outcomes.

Authors:  Javier Aragón; Itzell Pérez Méndez
Journal:  J Vis Surg       Date:  2016-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.